Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis

Background: Evidence is accumulating supporting a beneficial effect of vitamin D in multiple sclerosis (MS). Genome-wide association studies (GWAS) have shown significant associations between 25-hydroxyvitamin D (25(OH)D) and single nucleotide polymorphisms (SNPs) in key genes in the vitamin D metabolism. Objective: To examine the association between 25(OH)D and six GWAS SNPs and environmental factors in 1497 MS patients. Methods: Blood samples and lifestyle questionnaires were collected between 2009 and 2012. Genotyping of GC-, CYP2R1- and NADSYN1-SNPs was performed by TaqMan allelic discrimination (Life Technologies). Results: We found significant associations between 25(OH)D and SNPs in GC (rs7041, p = 0.01 and rs2282679, p = 0.03) and CYP2R1 (rs10741657, p =1.8 × 10−4). Season of blood sampling (p = 2.8 × 10−31), sex (p = 1.9 × 10−5), BMI (p = 2.3 × 10−5), vitamin supplements (p = 7.0 × 10−22), and fish intake (p = 0.02) also had significant effects on 25(OH)D. Conclusion: In this cross-sectional study, we found significant effects of environmental factors and SNPs in GC and CYP2R1 on 25(OH)D in MS patients. Since 25(OH)D might have protective effects in MS, and vitamin D supply is a modifiable factor, it may be important to include this in the MS treatment regimen.

[1]  K. Tucker,et al.  The longitudinal association of vitamin D serum concentrations & adiposity phenotype , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  M. Filippi,et al.  Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes , 2014, Multiple sclerosis.

[3]  T. Sørensen,et al.  Childhood body mass index and multiple sclerosis risk: a long-term cohort study , 2013, Multiple sclerosis.

[4]  Y. T. van der Schouw,et al.  Determinants of vitamin D status in healthy men and women aged 40-80 years. , 2013, Maturitas.

[5]  B. Laursen,et al.  The use of epidemiological multiple sclerosis registers in research: the Danish MS Registry , 2012, Acta neurologica Scandinavica. Supplementum.

[6]  G. Hallmans,et al.  Vitamin D as a protective factor in multiple sclerosis , 2012, Neurology.

[7]  C. McCulloch,et al.  Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis , 2012, Annals of neurology.

[8]  W. Hop,et al.  Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis , 2012, Neurology.

[9]  T. Olsson,et al.  High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women , 2012, Multiple sclerosis.

[10]  J. Stockman.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2012 .

[11]  J. Correale,et al.  Vitamin D-mediated immune regulation in Multiple Sclerosis , 2011, Journal of the Neurological Sciences.

[12]  T. Åkerstedt,et al.  Shift work at young age is associated with increased risk for multiple sclerosis , 2011, Annals of neurology.

[13]  Toshiko Tanaka,et al.  Genome-wide association study of circulating retinol levels , 2011, Human molecular genetics.

[14]  P. Kraft,et al.  Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis , 2011, Journal of Neurology.

[15]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[16]  T. Dwyer,et al.  Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.

[17]  Puneet Dhawan,et al.  Vitamin D: metabolism. , 2010, Endocrinology and metabolism clinics of North America.

[18]  E. Mowry,et al.  Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis , 2010, Annals of neurology.

[19]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[20]  T. Chitnis,et al.  Body size and risk of MS in two cohorts of US women , 2009, Neurology.

[21]  J. Correale,et al.  Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.

[22]  L. Mosekilde.  Vitamin D requirement and setting recommendation levels: long-term perspectives. , 2008, Nutrition reviews.

[23]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[24]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[25]  L. Airas,et al.  25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis , 2005, Multiple sclerosis.

[26]  L. Mosekilde,et al.  [The vitamin D status of the Danish population needs to be improved]. , 2005, Ugeskrift for laeger.

[27]  Jeffrey B. Cheng,et al.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Giovannucci,et al.  Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer , 2004, Cancer Causes & Control.

[29]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[30]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[31]  P. White,et al.  The Multifunctional Properties and Characteristics of Vitamin D-binding Protein , 2000, Trends in Endocrinology & Metabolism.

[32]  M. Holick,et al.  Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.

[33]  R. Swank,et al.  Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. , 1952, The New England journal of medicine.